相关实验视频
Updated: May 22, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
738
血清抗抑郁药的使用和临床显著出血的风险在血栓塞性血液恶性病患者
Hannah Delp1, Marissa Olson1, Emily Owen1
1Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, USA.
The Annals of pharmacotherapy
|March 15, 2025
概括
血红素再吸收抑制剂 (SRI) 抗抑郁药在患有血液恶性瘤和血小板狭窄症的患者中没有增加出血风险. 在这种人群中处方SRI时,建议对患者进行进一步的特定风险评估.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 血清素再吸收抑制剂 (SRIs) 具有抗血小板性质.
- 患有血液性恶性瘤 (HM) 的患者面临高出血风险,因为他们的病情和治疗诱导的血栓塞缩小.
研究的目的:
- 评估接受SRIs的HM和血小板缺血的患者临床显著出血 (CSB) 的风险.
主要方法:
- 成人HM患者的回顾性队列研究,患者患有血小板缩.
- 分层分为暴露于SRI和未暴露于SRI的组.
- 主要结局:CSB的发生率.
主要成果:
- 暴露于SRI (16%) 和未暴露 (13%) 组之间的CSB发生率没有显著差异 (P=0.487).
- 类似的住院时间和集中的住院时间在不同组之间.
- 在多变量分析中,SRI暴露与CSB没有独立相关 (aOR=1.46,95%CI 0.75-2.86).
结论:
- SRI使用与患有血小板狭窄症的HM患者中CSB增加无关.
- 由于研究的局限性和样本规模较小,个性化风险效益评估至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
Disorders of Hemostasis
674
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
674
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
266
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
266
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
171
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
171
Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143
Anticoagulant Drugs: Low-Molecular-Weight Heparins
586
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
586

